Johns Hopkins Arthritis Presents Highlights from EULAR 2001


	The Annual European Congress of Rheumatology was held in Prague, Czech Republic from June 13-16, 2001. This is the official meeting of the European Leagure Against Rheumatism (EULAR). Full abstract reports may be reviewed in the July edition of Annals of the Rheumatic Diseases 60, no. 1 suppl., 2001. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized below. The majority of these highlights focus on diseases whose predominant manifestation is arthritis (consistent with the mission of this WebSite). The highlights are summarized by Alan Matsumoto, M.D. and Jane McKenzie White, website project manager.
		Rheumatoid Arthritis-Treatments
	TNF Inhibitors COX-2 Inhibitors CTLA and LEA Animal Studies
		Rheumatoid Arthritis-Clinical
	Cardiovascular Disease Psychosocial Implications Polymorphonuclear Cells and Mortality Radiographic Progression Rheumatologist's Treatment Preferences
		Osteoarthritis-Treatments
	COX-2 Inhibitors Hyaluranon Glucosamine Sulfate
		Ankylosing Spondylitis
	TNF Inhibitors
	All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.